Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 173

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis

Open access
Hermine, Olivier, Lortholary, Olivier, Leventhal, Phillip S., Catteau, Adeline, Soppelsa, Frédérique, Baude, Cedric, Cohen-Akenine, Annick, Palmérini, Fabienne, Hanssens, Katia, Yang, Ying, Sobol, Hagay, Fraytag, Sylvie, Ghez, David, Suarez, Felipe, Barete, Stéphane, Casassus, Philippe, Sans, Beatrice, Arock, Michel, Kinet, Jean Pierre, Dubreuil, Patrice, Moussy, Alain · 2008 · PLoS ONE

Abstract

BACKGROUND: Indolent forms of mastocytosis account for more than 90% of all cases, but the types and type and severity of symptoms and their impact on the quality of life have not been well studied. We therefore performed a case-control cohort study to examine self-reported disability and impact of symptoms on the quality of life in patients with mastocytosis. METHODOLOGY/PRINCIPAL FINDINGS: In 2004, 363 mastocytosis patients and 90 controls in France were asked to rate to their overall disability (OPA score) and the severity of 38 individual symptoms. The latter was used to calculate a composite score (AFIRMM score). Of the 363 respondents, 262 were part of an ongoing pathophysiological study so that the following data were available: World Health Organization classification, standard measures of physical and psychological disability, existence of the D816V KIT mutation, and serum tryptase level. The mean OPA and AFIRMM scores and the standard measures of disability indicated that most mastocytosis patients suffer from disabilities due to the disease. Surprisingly, the patient's measurable and perceived disabilities did not differ according to disease classification or presence or absence of the D816V KIT mutation or an elevated (> or = 20 ng/mL) serum tryptase level. Also, 32 of the 38 AFIRMM symptoms were more common in patients than controls, but there were not substantial differences according to disease classification, presence of the D816V mutation, or the serum tryptase level. CONCLUSIONS: On the basis of these results and for the purposes of treatment, we propose that mastocytosis be first classified as aggressive or indolent and that indolent mastocytosis then be categorized according to the severity of patients' perceived symptoms and their impact on the quality of life. In addition, it appears that mastocytosis patients suffer from more symptoms and greater disability than previously thought, that mastocytosis may therefore be under-diagnosed, and that the symptoms of the indolent forms of mastocytosis might be due more to systemic release of mediators than mast cell burden.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0002266

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 173

Metadata

Authors
Hermine, O., Lortholary, O., Leventhal, P. S., Catteau, A., Soppelsa, F., Baude, C., Cohen-Akenine, A., Palmérini, F., Hanssens, K., Yang, Y., Sobol, H., Fraytag, S., Ghez, D., Suarez, F., Barete, S., Casassus, P., Sans, B., Arock, M., Kinet, J. P., Dubreuil, P., & Moussy, A.
Venue
PLoS ONE
Published
2008-05-28
Volume
3
Issue
5
Pages
e2266
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2046214587
Cited by
173
References
3
FWCI
1.82
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis. https://app.cochat.ai/papers/10.1371/journal.pone.0002266
The paper
Hermine, O., Lortholary, O., Leventhal, P. S., Catteau, A., Soppelsa, F., Baude, C., Cohen-Akenine, A., Palmérini, F., Hanssens, K., Yang, Y., Sobol, H., Fraytag, S., Ghez, D., Suarez, F., Barete, S., Casassus, P., Sans, B., Arock, M., Kinet, J. P., . . . Moussy, A. (2008). Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis. PLoS ONE. https://doi.org/10.1371/journal.pone.0002266

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.